Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed Quote. Delayed London Stock Exchange - 09/24 11:35:14 am
8845 GBX   +2.04%
09/24Health Care Stocks Retreat Friday
MT
09/24Eurostoxx 50 : European stocks slip on Evergrande woes, weak German business morale
RE
09/24European ADRs Move Lower in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus: Kenya has Received an Additional 410,000 Doses of AstraZeneca The Covax facility has also allocated Kenya 407,040 doses of AstraZeneca and 271,440 doses of Pfizer

08/01/2021 | 10:43am EDT

Kenya has received an additional 410,000 doses of AstraZeneca vaccine in yet another boost to ongoing efforts to vaccinate its adult population.

Speaking at JKIA after receiving the consignment, on behalf of Health CS Mutahi Kagwe, Health Chief Administrative Secretary Dr. Mercy Mwangangi said the donation will go a long way towards bolstering Kenya’s journey towards realising herd immunity."Our capacity for vaccine deployment remains very robust, but as is now common knowledge, our efforts have been greatly affected by supply constraints. When we receive donations such as what we have received today from friends and well-wishers, it is a deserved shot in the arm for our vaccination efforts." Said Dr. Mwangangi.

Foreign affairs CAS Ababu Namwamba said global solidarity remains key in the fight against the pandemic adding that it will ensure equitable access to the lifesaving vaccines.

British Deputy High Commissioner to Kenya Josephine Gauld said the consignment is the first batch of the 817,000 doses for Kenya with a further donation of 407,000 doses from the UK expected in the country via the COVAX facility.

Health Cabinet Secretary Mutahi Kagwe had yesterday announced that more vaccine doses will be arriving in the country beginning next week in a boost to the ongoing vaccination campaign. Kenya is also expecting to receive 1,760,000 doses of Pfizer from the US government.

A further 235,000 doses of Astrazeneca are expected in the country from Greece with an extra 55,000 doses of AstraZeneca set to arrive in the country from Lativia as part of bilateral donations.

The Covax facility has also allocated Kenya 407,040 doses of AstraZeneca and 271,440 doses of Pfizer. This besides the 13 million doses of Johnson and Johnson, procured by the government through the AVAT-AU mechanism, whose delivery will start next month.

The roll out of the national vaccination campaign is being led by the Ministry of Health, with support from WHO, UNICEF, Gavi and other partners. The Government of Kenya is currently prioritising second doses for health workers, teachers, other essential workers and people aged over 58.


Distributed by APO Group on behalf of Ministry of Health, Kenya.

© African Press Organization, source Press Releases

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 2.04% 8845 Delayed Quote.20.77%
PFIZER, INC. -0.57% 43.94 Delayed Quote.20.05%
All news about ASTRAZENECA PLC
09/24Health Care Stocks Retreat Friday
MT
09/24Eurostoxx 50 : European stocks slip on Evergrande woes, weak German business morale
RE
09/24European ADRs Move Lower in Friday Trading
MT
09/24ASTRAZENECA : Receives a Buy rating from Barclays
MD
09/24Wall Street Tumbles Pre-Bell, Evergrande Risks Resurface
MT
09/24Health Care Stocks Slip Pre-Bell Friday
MT
09/24IMPERIAL COLLEGE LONDON : Imperial RNA technology to be developed by VaxEquity with AstraZ..
AQ
09/24DEPARTMENT OF HEALTH AND SOCIAL CARE : check the rules for travel to England from abroad
AQ
09/24ASTRAZENECA : Lynparza in combination with abiraterone significantly delayed disease progr..
AQ
09/24ASTRAZENECA : LYNPARZA« (olaparib) in combination with abiraterone significantly delayed d..
BU
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 401 M - -
Net income 2021 5 006 M - -
Net Debt 2021 24 250 M - -
P/E ratio 2021 33,8x
Yield 2021 2,33%
Capitalization 187 B 187 B -
EV / Sales 2021 5,98x
EV / Sales 2022 4,85x
Nbr of Employees 76 100
Free-Float 96,3%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 120,91 $
Average target price 136,24 $
Spread / Average Target 12,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC20.77%187 304
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037